Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Convertible Debt (2019 - 2024)

Historic Convertible Debt for Regenerative Medical Technology (RMTG) over the last 6 years, with Q3 2024 value amounting to $40758.0.

  • Regenerative Medical Technology's Convertible Debt rose 2431.9% to $40758.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $40758.0, marking a year-over-year increase of 2431.9%. This contributed to the annual value of $35023.0 for FY2023, which is 640.32% down from last year.
  • Regenerative Medical Technology's Convertible Debt amounted to $40758.0 in Q3 2024, which was up 2431.9% from $37502.0 recorded in Q1 2024.
  • In the past 5 years, Regenerative Medical Technology's Convertible Debt registered a high of $220499.0 during Q2 2021, and its lowest value of $4898.0 during Q1 2020.
  • In the last 5 years, Regenerative Medical Technology's Convertible Debt had a median value of $35212.5 in 2022 and averaged $53015.4.
  • As far as peak fluctuations go, Regenerative Medical Technology's Convertible Debt skyrocketed by 601840.69% in 2020, and later tumbled by 8394.46% in 2022.
  • Regenerative Medical Technology's Convertible Debt (Quarter) stood at $148249.0 in 2020, then plummeted by 77.08% to $33982.0 in 2021, then increased by 10.11% to $37419.0 in 2022, then decreased by 6.4% to $35023.0 in 2023, then rose by 16.37% to $40758.0 in 2024.
  • Its Convertible Debt was $40758.0 in Q3 2024, compared to $37502.0 in Q1 2024 and $35023.0 in Q4 2023.